To synthesize current evidence into an integrated life-course framework explaining how obesogenic exposures, including maternal metabolic disease, postnatal adiposity, and endocrine disrupting chemicals, may interfere with testicular descent and gonadal maturation.
Approach:
Method: T
Method: h
Method: e
Method: r
Method: e
Method: v
Method: i
Method: e
Method: w
Method: i
Method: n
Method: t
Method: e
Method: g
Method: r
Method: a
Method: t
Method: e
Method: s
Method: h
Method: u
Method: m
Method: a
Method: n
Method: a
Method: n
Method: d
Method: e
Method: x
Method: p
Method: e
Method: r
Method: i
Method: m
Method: e
Method: n
Method: t
Method: a
Method: l
Method: e
Method: v
Method: i
Method: d
Method: e
Method: n
Method: c
Method: e
Method: a
Method: c
Method: r
Method: o
Method: s
Method: s
Method: p
Method: r
Method: e
Method: n
Method: a
Method: t
Method: a
Method: l
Method: l
Method: i
Method: f
Method: e
Method: ,
Method: m
Method: i
Method: n
Method: i
Method: p
Method: u
Method: b
Method: e
Method: r
Method: t
Method: y
Method: ,
Method: c
Method: h
Method: i
Method: l
Method: d
Method: h
Method: o
Method: o
Method: d
Method: ,
Method: a
Method: n
Method: d
Method: p
Method: u
Method: b
Method: e
Method: r
Method: t
Method: y
Method: ,
Method: f
Method: o
Method: c
Method: u
Method: s
Method: i
Method: n
Method: g
Method: o
Method: n
Method: L
Method: e
Method: y
Method: d
Method: i
Method: g
Method: c
Method: e
Method: l
Method: l
Method: h
Method: o
Method: r
Method: m
Method: o
Method: n
Method: e
Method: s
Method: ,
Method: h
Method: y
Method: p
Method: o
Method: t
Method: h
Method: a
Method: l
Method: a
Method: m
Method: i
Method: c
Method: -
Method: p
Method: i
Method: t
Method: u
Method: i
Method: t
Method: a
Method: r
Method: y
Method: -
Method: g
Method: o
Method: n
Method: a
Method: d
Method: a
Method: l
Method: a
Method: x
Method: i
Method: s
Method: r
Method: e
Method: g
Method: u
Method: l
Method: a
Method: t
Method: i
Method: o
Method: n
Method: ,
Method: s
Method: e
Method: x
Method: h
Method: o
Method: r
Method: m
Method: o
Method: n
Method: e
Method: b
Method: i
Method: n
Method: d
Method: i
Method: n
Method: g
Method: g
Method: l
Method: o
Method: b
Method: u
Method: l
Method: i
Method: n
Method: ,
Method: a
Method: r
Method: o
Method: m
Method: a
Method: t
Method: a
Method: s
Method: e
Method: a
Method: c
Method: t
Method: i
Method: v
Method: i
Method: t
Method: y
Method: ,
Method: l
Method: e
Method: p
Method: t
Method: i
Method: n
Method: a
Method: n
Method: d
Method: i
Method: n
Method: s
Method: u
Method: l
Method: i
Method: n
Method: s
Method: i
Method: g
Method: n
Method: a
Method: l
Method: i
Method: n
Method: g
Method: ,
Method: a
Method: n
Method: d
Method: e
Method: n
Method: d
Method: o
Method: c
Method: r
Method: i
Method: n
Method: e
Method: d
Method: i
Method: s
Method: r
Method: u
Method: p
Method: t
Method: o
Method: r
Method: e
Method: x
Method: p
Method: o
Method: s
Method: u
Method: r
Method: e
Method: .
Key Findings:
Maternal obesity and gestational metabolic disorders may be associated with impaired Leydig cell function and influence testicular development.
Postnatal and adolescent obesity may alter sex steroid balance and affect gonadal maturation.
Endocrine-disrupting chemicals may exacerbate disturbances in testicular descent and development.
Interpretation:
The findings suggest that cryptorchidism should be viewed within a broader developmental and metabolic context rather than as an isolated anomaly.
Limitations:
Most available human data linking obesity, endocrine-disrupting chemicals, and cryptorchidism are observational.
Proposed mechanisms should be interpreted as biologically plausible associations rather than established causal pathways.
Conclusion:
Integrating metabolic context into cryptorchidism management supports closer endocrine–urologic collaboration.
New studies separate host and microbial metabolites, trace secreted proteins, identify a pro-regenerative cardiomyocyte state, and map macrophage lipid metabolism